分子成像与上腺静脉采样用于检测手术可治愈的初级阿尔多斯特罗尼斯症:一个潜在的患者内试验

Emily Goodchild1, Xilin Wu1, Russell Senanayake2

  • 1Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; and Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom (E.G., X.W., G.A., K.L., Y.-N.L., J.K., W.M.D., M.J.B.).

PubMed
概括

使用[11C]metomidate ([11C]MTO) 的正子发射断层扫描 - 计算机断层扫描是一种用于原发性阿尔多斯特隆症 (PA) 的非侵入性诊断工具. 这种分子成像技术是准确的,并且与上腺静脉采样 (AVS) 不逊色,用于预测PA患者的手术结果.